Rapid Prototyping News and Research

RSS

Rapid prototyping uses advanced computer and laser technologies to produce complex three-dimensional prototypes in a fraction of the time required by more traditional technologies. The rapid prototyping process begins with a CAD solid model output to the appropriate RP file format. The file data is sliced into cross sections of 0.003 to 0.010 in. thickness. The cross sections are then fabricated in a layer additive process using one of the three available RP technologies.

MolGen Acquires Synchron

MolGen announced last Wednesday that it has acquired Dutch automation company Synchron Instrumenten BV, also known as Synchron Lab Automation.

From MolGen 28 Apr 2023

New system offers a potential solution for wide-scale stem cell production

Researchers have developed a unique 3D printed system for harvesting stem cells from bioreactors, offering the potential for high quality, wide-scale production of stem cells in Australia at a lower cost.

17 Jun 2022

Elective course in biodesign enables students to expand their abilities as medical device innovators

Educators at the Renaissance School of Medicine (RSOM) at Stony Brook University highlighted the success of their three-year, elective course in biodesign that has enabled students to expand their abilities as innovators to creating potential medical devices for the future.

11 May 2022

New approach to enhance cell-free biosynthesis with engineered yeast extracts

Think of cells as tiny factories: within their walls they have both the machinery to make products such as proteins, and the mechanisms for maintenance to keep processes running smoothly.

31 Aug 2021

Entos and Precision NanoSystems to develop vaccines and therapeutics using NanoAssemblr GMP System

Entos Pharmaceuticals, a healthcare biotechnology company developing next generation nucleic acid medicines with their Fusogenix delivery platform announced today a partnership with Precision NanoSystems, Inc., (PNI), a global leader in enabling transformative nanomedicines, to produce clinical grade vaccines and therapeutics using PNI's NanoAssemblr GMP System.

7 May 2020